Contemporary perspectives on the genetics and clinical use of lipoprotein (a) in preventive cardiology
MM Page, GF Watts - Current Opinion in Cardiology, 2021 - journals.lww.com
Measurement of Lp (a) in the clinical setting contributes to the assessment of ASCVD risk,
and will become more important with the advent of specific Lp (a)-lowering therapies …
and will become more important with the advent of specific Lp (a)-lowering therapies …
Contemporary perspectives on the genetics and clinical use of lipoprotein (a) in preventive cardiology
MM Page, GF Watts - Current opinion in cardiology, 2021 - pubmed.ncbi.nlm.nih.gov
Purpose of review The pathogenicity of lipoprotein (a)[Lp (a)] as a risk factor for
atherosclerotic cardiovascular disease (ASCVD) is well evidenced and recognized by …
atherosclerotic cardiovascular disease (ASCVD) is well evidenced and recognized by …
Contemporary perspectives on the genetics and clinical use of lipoprotein (a) in preventive cardiology
MM Page, GF Watts - Current Opinion in Cardiology, 2021 - ingentaconnect.com
Purpose of review The pathogenicity of lipoprotein (a)[Lp (a)] as a risk factor for
atherosclerotic cardiovascular disease (ASCVD) is well evidenced and recognized by …
atherosclerotic cardiovascular disease (ASCVD) is well evidenced and recognized by …
Contemporary perspectives on the genetics and clinical use of lipoprotein (a) in preventive cardiology.
MM Page, GF Watts - Current Opinion in Cardiology, 2021 - europepmc.org
Measurement of Lp (a) in the clinical setting contributes to the assessment of ASCVD risk,
and will become more important with the advent of specific Lp (a)-lowering therapies …
and will become more important with the advent of specific Lp (a)-lowering therapies …
Contemporary perspectives on the genetics and clinical use of lipoprotein (a) in preventive cardiology
MM Page, GF Watts - Current Opinion in …, 2021 - research-repository.uwa.edu.au
PURPOSE OF REVIEW: The pathogenicity of lipoprotein (a)[Lp (a)] as a risk factor for
atherosclerotic cardiovascular disease (ASCVD) is well evidenced and recognized by …
atherosclerotic cardiovascular disease (ASCVD) is well evidenced and recognized by …
Contemporary perspectives on the genetics and clinical use of lipoprotein (a) in preventive cardiology
MM Page, GF Watts - Current Opinion in Cardiology, 2021 - journals.lww.com
Measurement of Lp (a) in the clinical setting contributes to the assessment of ASCVD risk,
and will become more important with the advent of specific Lp (a)-lowering therapies …
and will become more important with the advent of specific Lp (a)-lowering therapies …